About us

Facilities and infrastructure at our Biomedical Research Centre — About the BRC

We undertake innovative translational research. We take leading-edge cancer research into a clinical setting and are the only BRC specialising in cancer.

As an NIHR BRC our aim is to drive pioneering research into the prevention, diagnosis and treatment of cancer, and to translate advances in biomedical research into patient benefits.

In 2006 The Royal Marsden and the ICR were awarded £10m per year as one of the original 12 Biomedical Research Centres. The award followed a competitive international peer review process, in which we were the only BRC applicant to have over 10% of the top-cited research papers in oncology. In 2011 and 2016 we were re-awarded BRC status.

Bench to bedside

The Royal Marsden and the ICR work to produce high quality scientific research, translational studies, and patient care. We have a joint research strategy which aims to combat cancer evolution and drug resistance.

We pride ourselves on pursuing excellence every step of the way, from meticulously designed bench experiments and clinical trials, to our level of bedside patient care when delivering new treatments. This is our ‘bench to bedside’ approach to cancer research.